Amaurosis fugax differential diagnosis

Amaurosis fugax Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Amaurosis fugax from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Diagnostic Evaluation
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Amaurosis fugax differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Amaurosis fugax differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Amaurosis fugax differential diagnosis
CDC on Amaurosis fugax differential diagnosis
Amaurosis fugax differential diagnosis in the news
Blogs on Amaurosis fugax differential diagnosis
Directions to Hospitals Treating Amaurosis fugax
Risk calculators and risk factors for Amaurosis fugax differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Leber's congenital amaurosis is an inherited disease resulting in severe vision loss or blindness that was first described by Theodore Leber in the 19th century. Amaurosis can also occur in ruminants suffering from a vitamin B1 (Thiamin) deficiency due to Thiamine-Related Cerebrocortical Necrosis (CCN).